Related Experiment Video
Updated: Feb 10, 2026
05:59
Author Spotlight: Advancing Antimicrobial Resistance Research with Innovative Approaches and Synthetic Compounds
Published on: September 27, 2024
2.5K
2,3,8-Trisubstituted Quinolines with Antimalarial Activity
Pablo D G Martinez1, Susann H Krake1, Maitia L Poggi1
1Instituto de Química, Universidade Estadual de Campinas, Campinas, SP, Brazil.
Anais Da Academia Brasileira De Ciencias
|May 24, 2018
Summary
Researchers identified a novel quinoline compound for malaria treatment. While initial tests showed high potency against Plasmodium falciparum, its effectiveness decreased against drug-resistant strains, highlighting challenges in developing new antimalarial drugs.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Discovery
Background:
- Combination therapy is crucial for malaria control, minimizing drug resistance.
- New antimalarial drugs with diverse mechanisms of action are needed for effective combination therapies.
- High-throughput screening (HTS) aids in identifying novel antimalarial drug candidates.
Purpose of the Study:
- To discover and optimize novel 2,3,8-trisubstituted quinoline compounds as potential antimalarial agents.
- To improve the physicochemical and pharmacokinetic (PK) properties of an initial hit compound.
- To evaluate the antimalarial activity of optimized derivatives against Plasmodium falciparum.
Main Methods:
- High-throughput screening (HTS) of chemical libraries to identify inhibitory compounds.
- Structure-activity relationship (SAR) studies and chemical synthesis to modify lead compounds.
- In vitro testing of Plasmodium falciparum NF54 strains to determine IC50 values.
- Assessment of cytotoxicity and evaluation of metabolic stability and solubility.
Main Results:
- A 2,3,8-trisubstituted quinoline compound demonstrated potent inhibition of P. falciparum NF54 (IC50 = 22 nM) with low cytotoxicity.
- Derivatives were synthesized with improved metabolic stability and solubility while retaining biological activity.
- The high potency observed in the initial compound was not maintained against drug-resistant Plasmodium strains.
Conclusions:
- Novel quinoline derivatives show promise as starting points for antimalarial drug development.
- Optimization of physicochemical properties is essential for developing viable drug candidates.
- Further research is needed to address activity against drug-resistant malaria parasites.
Related Concept Videos
02:04Co-activators and Co-repressors
8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
02:26tRNA Activation
23.0K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.0K
01:26Activation Energy
86.9K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.9K
02:42Eukaryotic Transcription Activators
12.9K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.9K
01:55Secondary Active Transport
138.1K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.1K
01:47Primary Active Transport
199.9K
In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
199.9K